Control NPs without KS-58 exhibited a slight trend toward slower tumor growth, but there was no statistically significant difference compared with the vehicle group (Fig. 4 A and Table 1 ).
← all excerpts
Nanoformulation of the K-Ras(G12D)-inhibitory peptide KS-58 suppresses colorectal and pancreatic cancer-derived tumors.
1
—
—